Iovance Biotherapeutics Inc

NASDAQ:IOVA  
24.94
-0.66 (-2.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Iovance Biotherapeutics Inc Stock, NASDAQ:IOVA

999 Skyway Road, Suite 150, San Carlos, California 94070
United States of America
Phone: +1.650.260.7120
Number of Employees: 241
http://www.iovance.com

Description

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.